- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/08 - Esters of oxyacids of phosphorus
Patent holdings for IPC class C07F 9/08
Total number of patents in this class: 41
10-year publication summary
0
|
3
|
7
|
5
|
4
|
2
|
3
|
1
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Abbvie Inc. | 1800 |
2 |
BioInteractions, Ltd. | 29 |
2 |
INVISTA North America S.a.r.l. | 176 |
2 |
Nalco Company | 563 |
2 |
Ramot at Tel-Aviv University Ltd. | 1475 |
2 |
Curadev Pharma Limited | 9 |
2 |
International Business Machines Corporation | 61228 |
1 |
FUJIFILM Corporation | 29367 |
1 |
Cheil Industries Inc. | 856 |
1 |
Dow Technology Investments LLC | 271 |
1 |
National Institute of Advanced Industrial Science and Technology | 3803 |
1 |
Agency for Science, Technology and Research | 3620 |
1 |
Alnylam Pharmaceuticals, Inc. | 1151 |
1 |
Bontac Bio-Engineering (Shenzhen) Co., Ltd | 72 |
1 |
Brightgene Bio-Medical Technology Co., Ltd. | 65 |
1 |
Butterworth Industries, Inc. | 11 |
1 |
Cellectar Biosciences, Inc. | 27 |
1 |
Central Glass Company, Limited | 1265 |
1 |
Hydrasyst IP Pty Ltd | 1 |
1 |
INVISTA Technologies S.a.r.l. | 415 |
1 |
Other owners | 15 |